Your browser doesn't support javascript.
loading
Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients.
Andersson, B S; Thall, P F; Valdez, B C; Milton, D R; Al-Atrash, G; Chen, J; Gulbis, A; Chu, D; Martinez, C; Parmar, S; Popat, U; Nieto, Y; Kebriaei, P; Alousi, A; de Lima, M; Rondon, G; Meng, Q H; Myers, A; Kawedia, J; Worth, L L; Fernandez-Vina, M; Madden, T; Shpall, E J; Jones, R B; Champlin, R E.
Afiliación
  • Andersson BS; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Thall PF; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Valdez BC; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Milton DR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Al-Atrash G; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Chen J; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Gulbis A; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Chu D; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Martinez C; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Parmar S; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Popat U; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Nieto Y; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kebriaei P; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Alousi A; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • de Lima M; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rondon G; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Meng QH; Division of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Myers A; Division of Pharmacy Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kawedia J; Division of Pharmacy Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Worth LL; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Madden T; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Shpall EJ; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Jones RB; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Champlin RE; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Bone Marrow Transplant ; 52(4): 580-587, 2017 Apr.
Article en En | MEDLINE | ID: mdl-27991894
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Trasplante Homólogo / Vidarabina / Síndromes Mielodisplásicos / Busulfano / Leucemia Mieloide Aguda / Monitoreo de Drogas / Acondicionamiento Pretrasplante Tipo de estudio: Clinical_trials / Etiology_studies / Guideline Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Trasplante Homólogo / Vidarabina / Síndromes Mielodisplásicos / Busulfano / Leucemia Mieloide Aguda / Monitoreo de Drogas / Acondicionamiento Pretrasplante Tipo de estudio: Clinical_trials / Etiology_studies / Guideline Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos